- 期刊
Development of a screening tool to detect nutrition risk in patients with inflammatory bowel disease
摘要
Background and Objectives: Malnutrition is a known complication of Inflammatory Bowel Disease (IBD). We assessed a known screening tool, as well as developed and validated a novel screening tool, to detect nutrition risk in outpatients with IBD. Methods and Study Design: The Saskatchewan IBD-Nutrition Risk (SaskIBD-NR Tool) was developed and administered alongside the Malnutrition Universal Screening Tool (MUST). Nutrition risk was confirmed by the IBD dietitian (RD) and gastroenterologist (GI). Agreement between screening tools and RD/GI assessment was computed using Cohen’s kappa. Results: Of the 110 patients screened, 75 (68.2%) patients had Crohn’s Disease and 35 (31.8%) ulcerative colitis. Mean BMI was 26.4 kg/m^2 (SD=5.8). RD/GI assessment identified 23 patients (20.9%) at nutrition risk. The SaskIBD-NR tool classified 21 (19.1%) at some nutrition risk, while MUST classified 17 (15.5%). The SaskIBD-NR tool had significant agreement with the RD/GI assessment (k 0.83, p＜0.001), while MUST showed a lack of agreement (k 0.15, p=0.12). The SaskIBD-NR had better sensitivity (82.6% vs 26.1%), specificity (97.7% vs 87.4%), positive predictive value (90.5% vs 35.3%), and negative predictive value (95.5% vs 81.7%) than the MUST. Conclusion: The SaskIBD-NR, which assesses GI symptoms, food restriction, and weight loss, adequately detects nutrition risk in IBD patients. Broader validation is required.
延伸閱讀
- Pakoz, Z. B., Cekic, C., Arabul, M., Yuksel, E. S., Ipek, S., Vatansever, S., & Unsal, B. (2015). An Evaluation of the Correlation between Hepcidin Serum Levels and Disease Activity in Inflammatory Bowel Disease. Gastroenterology Research and Practice, 2015(), 542-545-176. https://doi.org/10.1155/2015/810942
- Refaat, M. M., Ahmed, T. M., Eldin, S. S., Kamal, A. T., & Elnour, N. A. (2012). Atopic Manifestations in Patients with Inflammatory Bowel Disease. Journal of pioneering medical sciences, 2(3), 109-114. https://www.airitilibrary.com/Article/Detail?DocID=P20160812001-201209-201608150013-201608150013-109-114
- Xishan, Z., Ye, Z., Feiyan, M., & Shikai, W. (2013). Controlling nutritional score predict the individualized survival of patients with gastric cancer. Asia Pacific Journal of Clinical Nutrition, (), 1-16+18-00670. https://doi.org/10.6133/apjcn.202101/PP.0008
- Rutgeerts, P. (1998). The use of oral topically acting glucocorticosteroids in the treatment of inflammatory bowel disease. Mediators of Inflammation, 1998(), 137-140. https://doi.org/10.1080/09629359891036
- Plavsic, I., Hauser, G., Tkalcic, M., Pletikosic, S., & Salkic, N. (2015). Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers. Gastroenterology Research and Practice, 2015(), 715-726-085. https://doi.org/10.1155/2015/490183